233 related articles for article (PubMed ID: 10608165)
41. [The role of estradiol metabolites in prevention of cardiovascular diseases by hormone substitution in postmenopause].
Lippert TH; Seeger H; Mueck AO
Zentralbl Gynakol; 1999; 121(10):467-72. PubMed ID: 10573819
[TBL] [Abstract][Full Text] [Related]
42. [Prevention of cardiovascular risk in menopause women: role of ovarian hormones].
Rosano GM; Leonardo F; Ricci S; Serra GB; Chierchia SL
Ann Ist Super Sanita; 1997; 33(2):199-202. PubMed ID: 9470240
[TBL] [Abstract][Full Text] [Related]
43. [Cardiovascular effects of replacement hormones].
Kornitzer M; Hindlet JY
Rev Med Brux; 1995; 16(4):285-90. PubMed ID: 7481244
[TBL] [Abstract][Full Text] [Related]
44. [Secondary prevention in coronary diseases. Viewpoint of the gynecological endocrinologist].
Hänggi W
Praxis (Bern 1994); 1997 Jan; 86(5):145-9. PubMed ID: 9064732
[TBL] [Abstract][Full Text] [Related]
45. [Hormone replacement therapy and prevention of postmenopausal cardiovascular diseases].
Grand A
Ann Cardiol Angeiol (Paris); 1998; 47(7):481-7. PubMed ID: 9772970
[TBL] [Abstract][Full Text] [Related]
46. Postmenopausal hormone replacement therapy and the vascular wall: epidemiology and clinical studies.
Joswig M; Hach-Wunderle V; von Holst T; Nawroth PP
Vasa; 2000 Nov; 29(4):243-51. PubMed ID: 11141646
[TBL] [Abstract][Full Text] [Related]
47. New developments in postmenopausal hormone replacement therapy.
Prelevic GM; Jacobs HS
Curr Opin Obstet Gynecol; 1997 Jun; 9(3):207-12. PubMed ID: 9263706
[TBL] [Abstract][Full Text] [Related]
48. [Risk/benefit profile of hormone replacement therapy in postmenopause. From research to practice].
Terzian E
Ann Ist Super Sanita; 1997; 33(2):189-93. PubMed ID: 9470238
[TBL] [Abstract][Full Text] [Related]
49. Effects of hormone replacement therapy on coagulation, fibrinolysis, and thrombosis risk in postmenopausal women.
Koh KK; Horne MK; Cannon RO
Thromb Haemost; 1999 Aug; 82(2):626-33. PubMed ID: 10605760
[No Abstract] [Full Text] [Related]
50. Primary prevention of cardiovascular disease with hormone replacement therapy.
Schierbeck L
Climacteric; 2015; 18(4):492-7. PubMed ID: 25830825
[TBL] [Abstract][Full Text] [Related]
51. How much of the cardioprotective effect of postmenopausal estrogens is real?
Vandenbroucke JP
Epidemiology; 1995 May; 6(3):207-8. PubMed ID: 7619923
[No Abstract] [Full Text] [Related]
52. [The risks and benefits of hormone replacement therapy in postmenopausal women].
Zhang Y
Zhonghua Fu Chan Ke Za Zhi; 1997 Sep; 32(9):515-6. PubMed ID: 9639747
[No Abstract] [Full Text] [Related]
53. Smoking and postmenopausal hormone replacement therapy.
Jensen J
Br J Clin Pract Suppl; 1996 Sep; 86():6-8. PubMed ID: 8995003
[No Abstract] [Full Text] [Related]
54. ER-alpha variants and the cardiovascular effects of hormone replacement therapy.
Herrington DM; Howard TD
Pharmacogenomics; 2003 May; 4(3):269-77. PubMed ID: 12718718
[TBL] [Abstract][Full Text] [Related]
55. Reduction of serum uric acid by hormone replacement therapy in postmenopausal women with hyperuricaemia.
Sumino H; Ichikawa S; Kanda T; Nakamura T; Sakamaki T
Lancet; 1999 Aug; 354(9179):650. PubMed ID: 10466673
[TBL] [Abstract][Full Text] [Related]
56. Menopausal hormone treatment in postmenopausal women: risks and benefits.
Dous GV; Grodman R; Mornan A; Otterbeck P; Grigos A
South Med J; 2014 Nov; 107(11):689-95. PubMed ID: 25365435
[TBL] [Abstract][Full Text] [Related]
57. The menopause and lipid metabolism: strategies for cardiovascular disease prevention.
Soma MR; Baetta R; Crosignani P
Curr Opin Lipidol; 1997 Aug; 8(4):229-35. PubMed ID: 9253540
[TBL] [Abstract][Full Text] [Related]
58. Postmenopausal hormone therapy: the heart of the matter.
Guallar E; Manson JE; Laine C; Mulrow C
Ann Intern Med; 2013 Jan; 158(1):69-70. PubMed ID: 23277904
[No Abstract] [Full Text] [Related]
59. [Can postmenopausal hormone replacement therapy decrease the risk of cardiovascular disease?].
Kraft BW
Praxis (Bern 1994); 1999 Sep; 88(36):1439-42. PubMed ID: 10500419
[No Abstract] [Full Text] [Related]
60. The role of estrogen and estrogen-related drugs in cardiovascular diseases.
Ogita H; Node K; Kitakaze M
Curr Drug Metab; 2003 Dec; 4(6):497-504. PubMed ID: 14683477
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
